LOS ANGELES, Nov. 3, 2016 /PRNewswire/ -- Conference Series has been instrumental in conducting international metabolomics
8th Metabolomics Meeting to be held during May 11-13, 2017 at Singapore, Asia. 9th Analytical Metabolomics Meeting scheduled in Netherlands, Europe. 10th Conference and Exhibition on Metabolomics planned to be conducted at Baltimore during October 19-20, 2017. 8th International Conference on Proteomics and Bioinformatics, to be held during May 22-24, 2017 in Osaka, Japan. In Europe, Paris chosen for 9th Proteomics Meeting during October 23-25, 2017 and 10th Meeting scheduled in United States.
The Global Proteomics business sector is fast emerging globally and expected to reach $2,100 Million by 2019, with CAGR of 8.39% during 2014-2019. North America is pioneer with 42% of market share; followed by Europe with an offer of 38%.The Asia-Pacific's business sector is relied to develop at a CAGR of 23% amid the gauge period. Japan is the second largest life sciences market in the world after the United States. According to Data Monitor, Japanese biotechnology market is expected to grow from $43.3 billion in 2013 to $53.8 billion by 2017.
The global metabolomics market was valued at $712 million in 2012 and is expect to reach $1.4 billion by 2017, at a CAGR of 14.2%. Factors like increased scope of toxicological studies, clinical trials; rise in awareness for health & government and institution funds for research have immensely contributed for the rising demand for the metabolomics market. North America is the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019.
"We believe Metabolomics and proteomics are poised for disruption and the global demand for emerging -omics healthcare techniques will grow virtually inelastic as an indispensable spend. We've observed enormous growth in the areas of metabolomics and proteomics from last one decade and remain interested in this type of emerging markets" says Dr Srinubabu Gedela, CEO of OMICS International.
Everyone interested in the future of emerging -omics healthcare techniques majorly in metabolomics and proteomics is encouraged to attend. Connect with our social network pages to get regular industry updates.
About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.
PR Contact: firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/exploring-emerging-markets-in-metabolomics-and-proteomics-300356574.html
SOURCE OMICS International
Subscribe to our Free Newsletters!
Fallot's tetralogy is a rare and complex birth defect of the heart. Babies born with this condition ...
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...View All